Type(s) of breast cancer-Invasive ductal / lobular carcinoma - Page 2 of 5 Posts on Medivizor
Navigation Menu

Type(s) of breast cancer-Invasive ductal / lobular carcinoma Posts on Medivizor

Calpain-9 is associated with negative outlook following endocrine therapy

Calpain-9 is associated with negative outlook following endocrine therapy

Posted by on May 12, 2015 in Breast cancer | 0 comments

In a nutshell This article looked at the influence of calpain-9 on breast cancer survival following endocrine therapy. Some background Calpain-9 is a protein that is important in the processes of cell signalling (communication between cells). Irregular expression of these proteins can be seen in breast cancer and some of these proteins can even...

Read More

Skin-sparing mastectomy; an acceptable treatment?

Skin-sparing mastectomy; an acceptable treatment?

Posted by on Oct 25, 2014 in Breast cancer | 0 comments

In a nutshell This paper studied the outcomes of a skin-sparing mastectomy procedure. Some background More and more people are undergoing skin-sparing mastectomies. This is a treatment for breast cancer where breast tissue is removed, but the overlying skin is preserved as much as possible. It also allows for immediate breast...

Read More

FDA approved drugs in the last 20 years for the treatment of Metastatic Breast Cancer

FDA approved drugs in the last 20 years for the treatment of Metastatic Breast Cancer

Posted by on Aug 31, 2014 in Breast cancer | 0 comments

The article reviews drugs that were approved by the US Food and Drug Administration (FDA) for the treatment of Metastatic Breast Cancer (MBC) in the last 20 years. The authors summarize the clinical studies which lead to FDA approval. ‘First-line therapy’ is the initial treatment used to reduce cancer burden. It is usually the standard...

Read More

Circulating tumor DNA as a new biomarker

Circulating tumor DNA as a new biomarker

Posted by on Mar 19, 2014 in Breast cancer | 0 comments

In a nutshell This trial investigated the significance of circulating tumor DNA as a biomarker for monitoring response to treatment among metastatic breast cancer patients.  Some background The management of metastatic breast cancer requires frequent monitoring of response to treatment in order to avoid ineffective therapies and prevent...

Read More

Timing of adjuvant chemotherapy after surgery

Timing of adjuvant chemotherapy after surgery

Posted by on Feb 9, 2014 in Breast cancer | 0 comments

In a nutshell This study examined whether the timing of adjuvant chemotherapy affects survival among women with breast cancer. Some background Surgical resection to remove all cancerous tissue is the standard of care for the treatment of breast cancer. After surgery, many patients also undergo adjuvant treatments (additional therapy following...

Read More

A new treatment option for breast cancer

A new treatment option for breast cancer

Posted by on Sep 23, 2013 in Breast cancer | 1 comment

In a nutshell This phase II clinical trial examined the safety and efficacy of adding a drug called rh-endostatin (Endostar) to chemotherapy in breast cancer patients. Some background Cancer cells need blood supply in order to grow. As cancer grows, it forms its own blood vessels, a process called angiogenesis. Therefore, anti-angiogenesis...

Read More

Does removal of the primary tumor improve survival in stage IV breast cancer?

Does removal of the primary tumor improve survival in stage IV breast cancer?

Posted by on Sep 19, 2013 in Breast cancer | 0 comments

In a nutshell This analysis of several case studies evaluated whether removal of primary tumor in stage IV breast cancer helps improve overall survival. Some background In stage IV (metastatic) breast cancer, the cancer spreads beyond the breast and nearby lymph nodes, to other organs and tissues of the body, such as the lungs, liver, bones or...

Read More

Radiotherapy and tamoxifen can reduce the risk of recurrence in breast cancer patients who underwent conservative surgery

Radiotherapy and tamoxifen can reduce the risk of recurrence in breast cancer patients who underwent conservative surgery

Posted by on Sep 12, 2013 in Breast cancer | 0 comments

In a nutshell This study compared the benefits of radiotherapy and tamoxifen in reducing the risk of local recurrence (return of the cancer close to initial place of origin) in patients with early breast cancer who underwent breast conserving surgery (BCS). Some background Women with early breast cancer usually have tumors that are confined...

Read More

Epoetin alfa improves anemia associated with chemotherapy in breast cancer patients

Epoetin alfa improves anemia associated with chemotherapy in breast cancer patients

Posted by on Jul 27, 2013 in Breast cancer | 0 comments

In a nutshell In this study, researchers examined the effect of epoetin alfa (Epogen; Procrit) on anemia (low count of red blood cells) caused by chemotherapy in breast cancer patients. Some background Breast cancer is caused by a defect that makes some breast cancer cells grow and multiply rapidly. One of the treatment options for patients with...

Read More